N Kleindienst1, W E Severus, H-J Möller, W Greil. 1. Psychiatric Hospital of the University of Munich, Nussbaumstr. 7, 80336 Munich, Germany. nikolaus.kleindienst@med.uni-muenchen.de
Abstract
BACKGROUND: Recently published data might indicate that the polarity of recurrence is related to lithium serum levels. To systematically test this hypothesis all published maintenance trials in bipolar disorders were examined with regard to this issue. METHOD: Maintenance studies were subdivided in trials with low (i. e. below 0.6 mEq/l),medium (i. e. 0.6 to 0.8 mEq/l) and high (i. e. above 0.8 mEq/l) lithium serum levels. Percentage of depressive vs. (hypo-)manic or mixed recurrences were compared for these three groups. RESULTS: The percentage of depressive recurrences in the groups with low, medium and high lithium levels differed in a clinically and statistically significant manner (12% vs. 38% vs. 64%, p < 0.0001). CONCLUSION: The results might indicate that low lithium levels are effective in preventing depression whereas higher blood levels are needed to prevent (hypo-)manic or mixed states.
BACKGROUND: Recently published data might indicate that the polarity of recurrence is related to lithium serum levels. To systematically test this hypothesis all published maintenance trials in bipolar disorders were examined with regard to this issue. METHOD: Maintenance studies were subdivided in trials with low (i. e. below 0.6 mEq/l),medium (i. e. 0.6 to 0.8 mEq/l) and high (i. e. above 0.8 mEq/l) lithium serum levels. Percentage of depressive vs. (hypo-)manic or mixed recurrences were compared for these three groups. RESULTS: The percentage of depressive recurrences in the groups with low, medium and high lithium levels differed in a clinically and statistically significant manner (12% vs. 38% vs. 64%, p < 0.0001). CONCLUSION: The results might indicate that low lithium levels are effective in preventing depression whereas higher blood levels are needed to prevent (hypo-)manic or mixed states.
Authors: C L Bowden; J R Calabrese; S L McElroy; L Gyulai; A Wassef; F Petty; H G Pope; J C Chou; P E Keck; L J Rhodes; A C Swann; R M Hirschfeld; P J Wozniak Journal: Arch Gen Psychiatry Date: 2000-05
Authors: Joseph R Calabrese; Charles L Bowden; Gary Sachs; Lakshmi N Yatham; Kirsten Behnke; Olli-Pekka Mehtonen; Paul Montgomery; John Ascher; Walter Paska; Nancy Earl; Joseph DeVeaugh-Geiss Journal: J Clin Psychiatry Date: 2003-09 Impact factor: 4.384
Authors: Marcus V Zanetti; Maria C Otaduy; Rafael T de Sousa; Wagner F Gattaz; Geraldo F Busatto; Claudia C Leite; Rodrigo Machado-Vieira Journal: Int J Neuropsychopharmacol Date: 2014-10-31 Impact factor: 5.176
Authors: Willem A Nolen; Rasmus W Licht; Allan H Young; Gin S Malhi; Mauricio Tohen; Eduard Vieta; Ralph W Kupka; Carlos Zarate; René E Nielsen; Ross J Baldessarini; Emanuel Severus Journal: Bipolar Disord Date: 2019-06-20 Impact factor: 6.744